التفاصيل البيبلوغرافية
| العنوان: |
From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer. |
| المؤلفون: |
Samaratunga, Hemamali, Delahunt, Brett, Yaxley, John, Srigley, John R, Egevad, Lars |
| المصدر: |
Scandinavian Journal of Urology (Taylor & Francis Ltd); Oct2016, Vol. 50 Issue 5, p325-329, 5p |
| مصطلحات موضوعية: |
GLEASON grading system, PROSTATE cancer treatment, DIAGNOSIS, PROSTATE cancer, CRIBRIFORM plate, GLOMERELLA |
| مستخلص: |
Gleason grading of prostate cancer has gained worldwide acceptance since its introduction 50 years ago. This system has fulfilled the role of a powerful prognostic indicator for many years and this has influenced treatment. There have been numerous changes to the management and diagnosis of prostate cancer since 1966, including prostate-specific antigen screening, resulting in the early detection of prostate cancer, This has resulted in the evolution of Gleason grading with the informal adoption of a number of alterations. Significant changes to Gleason grading were made in 2005 through a consensus conference convened by the International Society of Urological Pathology (ISUP). In more recent times, the necessity for further changes to prostate cancer grading has been apparent and a follow-up ISUP consensus conference was held in 2014. Changes resulting from this conference included the classifying of all cribriform cancer and glomeruloid patterns as Gleason grade 4, the grading of mucinous adenocarcinoma based on underlying architecture rather than uniformly considering these tumors as pattern 4, and the introduction of a Gleason score (GS)-based 5 grade system, which incorporated the 2014 modifications to the Gleason grading system. Designated ISUP grade, this system consists of five grades: grade 1 (GS ≤3 + 3), grade 2 (GS 3 + 4), grade 3 (GS 4 + 3), grade 4 (GS 4 + 4, 3 + 5, 5 + 3) and grade 5 (GS 9–10). With further advances recently reported in the literature, it is apparent that amendments to the current system are likely to be necessary in the future. [ABSTRACT FROM PUBLISHER] |
|
Copyright of Scandinavian Journal of Urology (Taylor & Francis Ltd) is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
